Sanofi denied that its vaccine, the world's first against dengue, had caused any deaths. "There is currently no evidence directly linking the Dengvaxia vaccine to any of the 14 deaths," a spokesman responded in an email. "In Dengvaxia clinical trials conducted over more than a decade and the over one million doses of the vaccine administered, no deaths related to the vaccine have been reported to us."

"Initial Philippines Probe Finds 'Causal Association' Between Deaths, Sanofi Dengue Vaccine," published at 8:54 a.m. ET on Feb. 2, didn't include a more detailed company response.

(END) Dow Jones Newswires

February 15, 2018 11:45 ET (16:45 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
過去 株価チャート
から 3 2024 まで 4 2024 Sanofiのチャートをもっと見るにはこちらをクリック
Sanofi (EU:SAN)
過去 株価チャート
から 4 2023 まで 4 2024 Sanofiのチャートをもっと見るにはこちらをクリック